Do you have questions about getting a COVID-19 vaccine?

If you are on treatment for multiple sclerosis (MS) and have questions about COVID-19 or the COVID-19 vaccines, contact your healthcare provider for answers and guidance. It is very important to continue taking your MS medicine as prescribed and to follow your healthcare provider’s treatment directions.

For additional information, there are helpful online resources that address the question of whether people with MS should get a COVID-19 vaccine, including the National MS Society and the The Consortium of Multiple Sclerosis Centers. To learn more about your vaccination options, talk with your healthcare provider.

US-REB-00324 04/2021

WHY REBIF® (interferon beta-1a)

Navigating and treating RMS

Whether you’re newly diagnosed or more experienced in managing relapsing multiple sclerosis (RMS), living with the disease can be unpredictable. Starting or staying with a treatment is an important decision, and that’s why it is crucial to research different treatment options. When you and your healthcare provider are discussing what you want out of your treatment, you may want to keep these 3 important goals in mind:

 

Slow Disability Progression

Reduce Rate of Flare-ups

Reduce Number of New or Enlarging Brain Lesions

 

All RMS treatments have an effect on the immune system, your body’s natural defense system against harmful substances such as viruses, fungi, bacteria, toxins, and foreign particles. Although treatment may help reduce the frequency of relapses, it could also make you more vulnerable to many of the illnesses or medical challenges from which your immune system usually protects you. That’s why considering both safety and efficacy is important. Work with your healthcare provider to find an RMS treatment option that is right for you.

n
n

Reasons to consider Rebif® for your RMS

 

Image of a nurse and patient talking

Rebif® has proven results

Clinicial trials proved Rebif® effective in treating RMS in important ways compared to placebo, including fewer flare-ups. And Rebif® was proven superior to Avonex®, another interferon beta-1a RMS treatment, in a head-to-head study.

Image of a man in a maroon t-shirt outside smiling

Rebif® has a well-established safety profile

Through 20+ years of combined clinical trial data and real-world patient experience, Rebif® has a well-established safety profile and has been prescribed to more than 145,000 patients in the US since 2002.

Image of a man and a woman lounging in a relaxed setting looking at a laptop

Rebif® offers options

Rebif® gives you the choice of 3 injection devices and the ability to choose 3 dosing days, 48 hours apart, that work best for you.

Image of a nurse talking with a patient

Rebif® gives you support

If you take Rebif®, you have free access to caring experts—including Financial Specialists for guidance on insurance coverage and MS-certified nurses for questions about treatment. 

n
n
Point icon

Choosing your treatment

Gain insights into navigating your treatment options, whether you are newly diagnosed or more experienced in managing RMS.

Baby Carriage icon

Family planning when you have RMS

See data to learn about considerations for family planning while taking Rebif®

 

$0 icon

Get $0 co-pay* info

See if you may be able to receive Rebif® at no cost to you. 

Pamphlet icon

Order free information kit

Want more information about Rebif®? Get our free kit. 

*People with insurance or co-insurance may be eligible.
Attention Patients: Federal and state healthcare program beneficiaries are not eligible for the MS LifeLines® $0 co-pay program. If you participate in a federal or state healthcare program, including Medicare, Medicaid, TRICARE, the Department of Veterans Affairs, the Department of Defense, or any other similar federal or state healthcare program, including any state medical pharmaceutical assistance program, you are not eligible to utilize the MS LifeLines® $0 co-pay program.

 


IMPORTANT SAFETY INFORMATION AND INDICATION

Important Safety Information

Before beginning treatment, you should discuss the potential benefits and risks associated with Rebif with your healthcare provider.

Rebif can cause serious side effects. Tell your healthcare provider right away if you have any of the symptoms listed below while taking Rebif.

  • Behavioral health problems including depression and suicidal thoughts. You may have mood problems including depression (feeling hopeless or feeling bad about yourself), and thoughts of hurting yourself or suicide
  • Liver problems or worsening of liver problems including liver failure. Symptoms may include nausea, loss of appetite, tiredness, dark colored urine and pale stools, yellowing of your skin or the white part of your eye, bleeding more easily than normal, confusion, and sleepiness. During your treatment with Rebif you will need to see your healthcare provider regularly and have regular blood tests to check for side effects
  • Serious allergic and skin reactions. Symptoms may include itching, swelling of your face, eyes, lips, tongue or throat, trouble breathing, anxiousness, feeling faint, skin rash, hives, sores in your mouth, or skin blisters and peels
  • Injection site problems. Symptoms at the injection site may include redness, pain, swelling, color changes (blue or black), and drainage of fluid
  • Blood problems. Rebif can affect your bone marrow and cause low red and white blood cell and platelet counts. In some people, these blood cell counts may fall to dangerously low levels. If your blood cell counts become very low, you can get infections and problems with bleeding and bruising. Your healthcare provider may ask you to have regular blood tests to check for blood problems
  • Seizures. Some people have had seizures while taking Rebif

Rebif will not cure your MS but may decrease the number of flare-ups of the disease and slow the occurrence of some of the physical disability that is common in people with MS.

Do not take Rebif if you are allergic to interferon beta, human albumin, or any of the ingredients in Rebif.

Before you take Rebif, tell your healthcare provider if you have or have had any of the following conditions:

  • mental illness, including depression and suicidal behavior
  • liver problems, bleeding problems or blood clots, low blood cell counts, seizures (epilepsy), or thyroid problems
  • you drink alcohol
  • you are pregnant or plan to become pregnant. It is not known if Rebif will harm your unborn baby
  • you are breastfeeding or plan to breastfeed. Rebif may pass into your breastmilk. Talk with your healthcare provider about the best way to feed your baby if you take Rebif

Tell your healthcare provider about all medicines you take, including prescription and over-the-counter medicines, vitamins and herbal supplements.

The most common side effects of Rebif include:

  • flu-like symptoms. You may have flu-like symptoms when you first start taking Rebif. You may be able to manage these flu-like symptoms by taking over-the-counter pain and fever reducers. For many people, these symptoms lessen or go away over time. Symptoms may include muscle aches, fever, tiredness, and chills
  • stomach pain
  • change in liver blood tests

Tell your healthcare provider if you have any side effect that bothers you or that does not go away.

These are not all the possible side effects of Rebif. For more information, ask your healthcare provider or pharmacist.

Call your doctor for medical advice about side effects. 

You are encouraged to report negative side effects of prescription drugs to FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Indication

Rebif® (interferon beta-1a) is a prescription medicine used to treat relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.